<a target=new class=ftalternatingbarlinklarge href="http://www.signonsandiego.com/news/business/biotech/20051021-9999-1b21vertex.html
">http://www.signonsandiego.com/news/business/biotech/20051021-9999-1b21vertex.html
</a>
Excerpts:
This month, Vertex named as one of its key drug development projects for 2006 an experimental treatment for cystic fibrosis that was discovered at its San Diego site.
Though other experimental Vertex drugs have garnered more attention ? a Hepatitis C drug about to go into Phase 2 testing is generating most of the buzz ? the cystic fibrosis treatment represents a milestone for Vertex's West Coast research hub, which employs 150.
Bob Beall, chief executive officer of the CF Foundation, said the Vertex drug is the foundation's "highest priority research project."
"The collaboration has been outstanding," said Beall, whose foundation has provided $40 million to fund the Vertex CF project. "We think this approach is custom-made, it aims right at the level of the basic gene defect and mutation that causes cystic fibrosis.
"If it works out, it would be the most significant advance in the history of CF," Beall said.
">http://www.signonsandiego.com/news/business/biotech/20051021-9999-1b21vertex.html
</a>
Excerpts:
This month, Vertex named as one of its key drug development projects for 2006 an experimental treatment for cystic fibrosis that was discovered at its San Diego site.
Though other experimental Vertex drugs have garnered more attention ? a Hepatitis C drug about to go into Phase 2 testing is generating most of the buzz ? the cystic fibrosis treatment represents a milestone for Vertex's West Coast research hub, which employs 150.
Bob Beall, chief executive officer of the CF Foundation, said the Vertex drug is the foundation's "highest priority research project."
"The collaboration has been outstanding," said Beall, whose foundation has provided $40 million to fund the Vertex CF project. "We think this approach is custom-made, it aims right at the level of the basic gene defect and mutation that causes cystic fibrosis.
"If it works out, it would be the most significant advance in the history of CF," Beall said.